Showing results (31-40 of 93) with videos related to

Sort By:
Pageof 10
Cancer Immunology, Immunotherapy : CII|March 20, 2012
Metastatic melanoma patients treated with dendritic cell vaccination, Interleukin-2 and metronomic cyclophosphamide: results from a phase II trialEva Ellebaek, Lotte Engell-Noerregaard, Trine Zeeberg Iversen, et al.
Cytotherapy|March 24, 2020
Common phenotypic dynamics of tumor-infiltrating lymphocytes across different histologies upon checkpoint inhibition: impact on clinical outcomeVinicius Araujo B de Lima, Annie Borch, Morten Hansen, et al.
Science Immunology|April 15, 2021
SARS-CoV-2 genome-wide T cell epitope mapping reveals immunodominance and substantial CD8+ T cell activation in COVID-19 patientsSunil Kumar Saini, Ditte Stampe Hersby, Tripti Tamhane, et al.
Cancers|January 11, 2022
Novel Molecular Targets for Hepatocellular CarcinomaBeatrice Cavalluzzo, Angela Mauriello, Concetta Ragone, et al.
Scientific Reports|August 2, 2023
Engineered E. coli Nissle 1917 for delivery of bioactive IL-2 for cancer immunotherapySarunas Tumas, Trine Sundebo Meldgaard, Troels Holger Vaaben, et al.
International Journal of Cancer|March 25, 2006
Tumor infiltrating lymphocytes in seminoma lesions comprise clonally expanded cytotoxic T cellsSine Reker Hadrup, Otto Braendstrup, Grete Krag Jacobsen, et al.
Oncoimmunology|September 28, 2013
High frequency of T cells specific for cryptic epitopes in melanoma patientsRikke Sick Andersen, Sofie Ramskov Andersen, Mads Duus Hjortsø, et al.
Cytometry. Part a : the Journal of the International Society for Analytical Cytology|October 10, 2014
Cryopreservation of MHC multimers: Recommendations for quality assurance in detection of antigen specific T cellsSine Reker Hadrup, Dominik Maurer, Karoline Laske, et al.
Cytometry. Part a : the Journal of the International Society for Analytical Cytology|June 3, 2015
Design and validation of conditional ligands for HLA-B*08:01, HLA-B*15:01, HLA-B*35:01, and HLA-B*44:05Thomas Mørch Frøsig, Jiawei Yap, Tina Seremet, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|February 15, 2014
T-cell responses to oncogenic merkel cell polyomavirus proteins distinguish patients with merkel cell carcinoma from healthy donorsRikke Lyngaa, Natasja Wulff Pedersen, David Schrama, et al.
Pageof 10